If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rikke Fredslund Andersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer

    Thomsen, C. B., Hansen, T. F., Andersen, R. F., Lindebjerg, J., Jensen, L. H. & Jakobsen, A., 26. May 2020, In : Therapeutic Advances in Medical Oncology. 12, p. 1-7

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

    Jensen, L. H., Andersen, R. F., Byriel, L., Fernebro, E., Jakobsen, A., Lindebjerg, J., Nottelmann, L., Ploen, J. & Hansen, T. F., Mar 2020, In : Acta oncologica (Stockholm, Sweden). 59, 3, p. 298-301

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Correlation between tumor-specific mutated and methylated DNA in colorectal cancer

    Thomsen, C. B., Andersen, R. F., Lindebjerg, J., Hansen, T. F., Jensen, L. H. & Jakobsen, A., 2019, In : JCO Precision Oncology. 3, p. 1-8

    Research output: Contribution to journalJournal articleResearchpeer-review

    Open Access
    File
  • 10 Downloads (Pure)

    Activities

    • 2 Talks and presentations in private or public companies
    • 1 Conference organisation or participation
    • 1 Board duties in companies, associations, or public organisations

    Plasma DNA in personalized medicine: Methods, technology, equipment and application for diagnosis and monitoring of treatment effect.

    Ivan Brandslund (Lecturer), Rikke Fredslund Andersen (Lecturer)
    9. Mar 2017

    Activity: Talks and presentationsTalks and presentations in private or public companies

    The prognostic value of genetic variations in the vascular endothelial growth factor A gene in colorectal cancer

    Rikke Fredslund Andersen (Speaker)
    28. Mar 201030. Mar 2010

    Activity: Talks and presentationsTalks and presentations in private or public companies

    Kursus i Sygdomsdiagnostik

    Rikke Fredslund Andersen (Participant)
    6. May 20088. May 2008

    Activity: Attending an eventConference organisation or participation

    Dansk Selskab for Klinisk Biokemi (External organisation)

    Rikke Fredslund Andersen (Member)
    1. Feb 2008 → …

    Activity: MembershipBoard duties in companies, associations, or public organisations